Functional genomic and high-content screening for target discovery and deconvolution

By Heynen-Genel Susanne   Pache Lars   Chanda Sumit K   Rosen Jonathan  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 10, 2012-01 ,pp. : 955-968

Informa Healthcare

Access to resources Recommend Favorite

High-content siRNA screening for target identification and validation

By Krausz Eberhard   Korn Kerstin  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 5, 2008-05 ,pp. : 551-564

Informa Healthcare

Access to resources Recommend Favorite

Computational methods to support high-content screening: from compound selection and data analysis to postulating target hypotheses

By Kümmel Anne   Gabriel Daniela   Parker Christian N   Bender Andreas  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 5-13

Informa Healthcare

Access to resources Recommend Favorite

High-content screening for the discovery of pharmacological compounds: advantages, challenges and potential benefits of recent technological developments

By Soleilhac Emmanuelle   Nadon Robert   Lafanechere Laurence  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 2, 2010-02 ,pp. : 135-144

Informa Healthcare

Access to resources Recommend Favorite

The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome

By Vernon Suzanne D   Reeves William C  

Pharmacogenomics, Vol. 7, Iss. 3, 2006-04 ,pp. : 345-354

Future Medicine

Access to resources Recommend Favorite